During the period, オキサイド's share price fell sharply, while the company disclosed a capital and business alliance with JX Advanced Metals and a capital increase through a third-party allotment. Results for the interim period of the fiscal year ending February 2027 showed a return to profitability and an improved financial position.
Over the five trading days from 11/16, the share price fell from ¥3,175 to ¥2,587, and on 11/10 it temporarily hit the daily price limit at ¥2,968, up ¥500 from the previous day, before continuing to trend lower.
News disclosed on the same day included the announcement of a capital and business alliance with JX Advanced Metals and a capital increase through a third-party allotment. The market subsequently experienced volatile back-and-forth trading over a short period.
In the earnings release, revenue for the interim period of the fiscal year ending February 2027 rose 18.9% year on year to ¥4.9 billion, driven mainly by the semiconductor business, while operating profit and net income turned profitable. The equity ratio improved to 34.7%, strengthening the financial position. Meanwhile, continued increases in the cost of healthcare materials remain an area to watch.